ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Entyvio subkutan 108 mg, Injektionslösung in einer Fertigspritze - 
67537001 Takeda Pharma AG
Entyvio subkutan 108 mg, Injektionslösung in einer Fertigspritze16.10.2020
  16.10.2020
Vedolizumab (L04AA33) 
WHO-DDD15.10.2025
07.15. 
07.15. 
A  
Yes 
IPCI
544.26Yes
    
10 %608.35
7680675370016Biotechnologika
  
Composition
vedolizumabum 108 mg, acidum citricum monohydricum, natrii citras dihydricus corresp. natrium 1.11 mg, histidinum, histidini hydrochloridum monohydricum, arginini hydrochloridum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 0.68 ml.
Packungsbestandteile
Injection solution in prefilled syringe 
  
 
Active AgentDose
Vedolizumabum108mg / 0.68ml
BAG: Active AgentDose
Vedolizumabum108 mg
 
Inactive agents
Citric Acid Monohydrate
Arginine Hydrochloride
Histidin Hydrochloride Monohydrate
Histidine
Natrii Citras Dihydricus
Polysorbatum 80
 
Source
Data was imported : 07.08.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home